How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Fibonacci Retracements Explained: How to Spot Key Reversal Levels in 2026 Read what the experts are trading this weekExclusive analysis from FXEmpire top analysts — curated insights you won't find on ...

Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician (CMT). Katrina Ávila Munichiello is an experienced editor, writer, fact-checker, and ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Thomas J. Brock is a CFA and CPA with more than 20 years of experience in various areas including investing, ...

Jan. 14, 2025 A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings ...

Dwyer et al. apply multi-contrast post-processing and deep learning to standard MRI scans from a large multiple sclerosis clinical trial to quantify cortical lesions. They show that combining enhanced ...

Multiple sclerosis (MS) is a chronic autoimmune disease that impacts the central nervous system, disrupting the flow of information between your brain and body. Symptoms range widely but can include ...

RSI Indicator Explained: How to Read Momentum and Time Trades in 2026 US Dollar Index slips to 98.58 as retail sales plunge 0.9% and industrial production drops for a second time in three months.